Your browser doesn't support javascript.
loading
Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.
Richter-Pechanska, Paulina; Kunz, Joachim B; Rausch, Tobias; Erarslan-Uysal, Büsra; Bornhauser, Beat; Frismantas, Viktoras; Assenov, Yassen; Zimmermann, Martin; Happich, Margit; von Knebel-Doeberitz, Caroline; von Neuhoff, Nils; Köhler, Rolf; Stanulla, Martin; Schrappe, Martin; Cario, Gunnar; Escherich, Gabriele; Kirschner-Schwabe, Renate; Eckert, Cornelia; Avigad, Smadar; Pfister, Stefan M; Muckenthaler, Martina U; Bourquin, Jean-Pierre; Korbel, Jan O; Kulozik, Andreas E.
Affiliation
  • Richter-Pechanska P; Department of Pediatric Oncology, Hematology, and Immunology, University of Heidelberg, Heidelberg, Germany.
  • Kunz JB; Hopp Children´s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Rausch T; Molecular Medicine Partnership Unit (MMPU), EMBL and Medical Faculty of the University of Heidelberg, Heidelberg, Germany.
  • Erarslan-Uysal B; Department of Pediatric Oncology, Hematology, and Immunology, University of Heidelberg, Heidelberg, Germany.
  • Bornhauser B; Hopp Children´s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Frismantas V; Molecular Medicine Partnership Unit (MMPU), EMBL and Medical Faculty of the University of Heidelberg, Heidelberg, Germany.
  • Assenov Y; Molecular Medicine Partnership Unit (MMPU), EMBL and Medical Faculty of the University of Heidelberg, Heidelberg, Germany.
  • Zimmermann M; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
  • Happich M; Department of Pediatric Oncology, Hematology, and Immunology, University of Heidelberg, Heidelberg, Germany.
  • von Knebel-Doeberitz C; Hopp Children´s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • von Neuhoff N; Molecular Medicine Partnership Unit (MMPU), EMBL and Medical Faculty of the University of Heidelberg, Heidelberg, Germany.
  • Köhler R; Division of Pediatric Oncology, University Children's Hospital, Zürich, Switzerland.
  • Stanulla M; Division of Pediatric Oncology, University Children's Hospital, Zürich, Switzerland.
  • Schrappe M; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cario G; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Escherich G; Department of Pediatric Oncology, Hematology, and Immunology, University of Heidelberg, Heidelberg, Germany.
  • Kirschner-Schwabe R; Hopp Children´s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Eckert C; Department of Pediatric Oncology, Hematology, and Immunology, University of Heidelberg, Heidelberg, Germany.
  • Avigad S; Hopp Children´s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Pfister SM; Molecular Medicine Partnership Unit (MMPU), EMBL and Medical Faculty of the University of Heidelberg, Heidelberg, Germany.
  • Muckenthaler MU; Department of Pediatrics III, University Hospital, University of Duisburg-Essen, Essen, Germany.
  • Bourquin JP; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
  • Korbel JO; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Kulozik AE; Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Leukemia ; 36(7): 1759-1768, 2022 07.
Article in En | MEDLINE | ID: mdl-35585141
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Limits: Child / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Limits: Child / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: Germany